A Phase I/II trial of DPV-001 in combination with anti-PD-1 antibody for Non-Small Cell Lung Cancer (NSCLC).
Phase of Trial: Phase I/II
Latest Information Update: 12 Sep 2016
At a glance
- Drugs DPV 001 (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 12 Sep 2016 New trial record